Latest News Archive
Please select Category, Year, and then Month to display items
14 May 2024
|
Story ANTHONY MTHEMBU
|
Photo Supplied
Contemporary artist Ibrahim Mahama engaging with students during his visit to the Department of Fine Arts at the University of the Free State (UFS).
Ghanaian contemporary artist, Ibrahim Mahama, visited the Department of Fine Arts at the University of the Free State (UFS) to share insights with staff and students during his stay in the country.
Dr Adelheid Von Maltitz, Senior Lecturer in the Department of Fine Arts at the UFS, highlighted the significance of Mahama’s visit which took place from 21 to 28 March 2024, marking the first instance of such interaction between a Fine Arts department in South Africa and Mahama. She remarked, “It is truly astounding that a person of his calibre dedicated time to focus on our department, and I believe this has catalysed a positive shift within our department.”
Mahama’s impactful presence at UFS
Dr Von Maltitz emphasised that Mahama’s visit aimed to offer staff and students a glimpse into his artistic process and mindset. During his time at the UFS, Mahama, who was virtually overseeing his latest recent large-scale artwork titled Purple Hibiscus, which involved wrapping the Barbican Centre in London, engaged extensively with staff and students from the department about their research. He shared insights into his creative journey, presented select works, and conducted critique sessions with fourth year and postgraduate students, among other activities. Dr Von Maltitz believes this interaction, particularly with students, has significantly bolstered their confidence as aspiring artists, preparing them for professional endeavours.
Broader implications and future prospects
Mahama’s visit not only energised the department’s academic environment but also holds broader implications. Dr Von Maltitz asserted that it will solidify the department’s identity nationally and create avenues for students to pursue residencies in countries like Ghana. Therefore, maintaining a fruitful relationship with Mahama remains a priority for the department.
Reflecting on the visit Dr Von Maltitz concluded, ‘’the key takeaway, especially for the students, was witnessing the potential of their works within the broader South African and international contexts. “
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”